Cargando…
Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report
INTRODUCTION AND IMPORTANCE: Cancer of unknown primary site (CUP) is metastatic cancer without primary tumor found from comprehensive medical history, physical examination, and regular laboratory examination. Eighty percent of CUP include unfavorable groups with 3 to 6 months of median survival desp...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961183/ https://www.ncbi.nlm.nih.gov/pubmed/35339815 http://dx.doi.org/10.1016/j.ijscr.2022.106954 |
_version_ | 1784677543453917184 |
---|---|
author | Yulian, Erwin Danil Hwei, Lie Rebecca Yen Tambun, Renaningtyas Siswoyo, Alvita Dewi Ham, Maria Fransisca Suroyo, Indrati |
author_facet | Yulian, Erwin Danil Hwei, Lie Rebecca Yen Tambun, Renaningtyas Siswoyo, Alvita Dewi Ham, Maria Fransisca Suroyo, Indrati |
author_sort | Yulian, Erwin Danil |
collection | PubMed |
description | INTRODUCTION AND IMPORTANCE: Cancer of unknown primary site (CUP) is metastatic cancer without primary tumor found from comprehensive medical history, physical examination, and regular laboratory examination. Eighty percent of CUP include unfavorable groups with 3 to 6 months of median survival despite chemotherapy treatment. CASE PRESENTATION: A 52-year-old male was presented with a chief complaint of a recurrent lump in the neck and axilla. After comprehensive examinations over three years, the primary site of the metastatic tumor could not be found. Therefore, this patient was diagnosed with cancer of an unknown primary site. CLINICAL DISCUSSION: In patient with CUP, more precise therapy can only begin when the exact form of cancer is identified. However, the delay in diagnosis would worsen the patient's condition, as treatment measures cannot be implemented. CONCLUSION: Trimodal modalities including surgery, chemotherapy, and radiotherapy are suitable for CUP with squamous cell carcinoma proven in immunohistochemistry evaluation. |
format | Online Article Text |
id | pubmed-8961183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-89611832022-03-30 Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report Yulian, Erwin Danil Hwei, Lie Rebecca Yen Tambun, Renaningtyas Siswoyo, Alvita Dewi Ham, Maria Fransisca Suroyo, Indrati Int J Surg Case Rep Case Report INTRODUCTION AND IMPORTANCE: Cancer of unknown primary site (CUP) is metastatic cancer without primary tumor found from comprehensive medical history, physical examination, and regular laboratory examination. Eighty percent of CUP include unfavorable groups with 3 to 6 months of median survival despite chemotherapy treatment. CASE PRESENTATION: A 52-year-old male was presented with a chief complaint of a recurrent lump in the neck and axilla. After comprehensive examinations over three years, the primary site of the metastatic tumor could not be found. Therefore, this patient was diagnosed with cancer of an unknown primary site. CLINICAL DISCUSSION: In patient with CUP, more precise therapy can only begin when the exact form of cancer is identified. However, the delay in diagnosis would worsen the patient's condition, as treatment measures cannot be implemented. CONCLUSION: Trimodal modalities including surgery, chemotherapy, and radiotherapy are suitable for CUP with squamous cell carcinoma proven in immunohistochemistry evaluation. Elsevier 2022-03-16 /pmc/articles/PMC8961183/ /pubmed/35339815 http://dx.doi.org/10.1016/j.ijscr.2022.106954 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Yulian, Erwin Danil Hwei, Lie Rebecca Yen Tambun, Renaningtyas Siswoyo, Alvita Dewi Ham, Maria Fransisca Suroyo, Indrati Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report |
title | Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report |
title_full | Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report |
title_fullStr | Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report |
title_full_unstemmed | Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report |
title_short | Comprehensive evaluation on cancer of unknown primary site and how we managed it: A case report |
title_sort | comprehensive evaluation on cancer of unknown primary site and how we managed it: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961183/ https://www.ncbi.nlm.nih.gov/pubmed/35339815 http://dx.doi.org/10.1016/j.ijscr.2022.106954 |
work_keys_str_mv | AT yulianerwindanil comprehensiveevaluationoncancerofunknownprimarysiteandhowwemanageditacasereport AT hweilierebeccayen comprehensiveevaluationoncancerofunknownprimarysiteandhowwemanageditacasereport AT tambunrenaningtyas comprehensiveevaluationoncancerofunknownprimarysiteandhowwemanageditacasereport AT siswoyoalvitadewi comprehensiveevaluationoncancerofunknownprimarysiteandhowwemanageditacasereport AT hammariafransisca comprehensiveevaluationoncancerofunknownprimarysiteandhowwemanageditacasereport AT suroyoindrati comprehensiveevaluationoncancerofunknownprimarysiteandhowwemanageditacasereport |